RET codon 804 mutations in multiple endocrine neoplasia 2: genotype-phenotype correlations and implications in...

Area of Science:

• Endocrinology
• Genetics
• Oncology

Background:

• Multiple endocrine neoplasia type 2 (MEN 2) is a hereditary cancer syndrome.
• Germline mutations in the RET proto-oncogene are the underlying cause of MEN 2.
• While cysteine-rich domain mutations are well-studied, non-cysteine RET mutations are less understood.

Purpose of the Study:

• To review the genotypic and phenotypic characteristics of non-cysteine RET mutations in MEN 2.
• To highlight the clinical heterogeneity associated with these mutations.
• To focus on RET codon 804 mutations as a representative example.

Main Methods:

• Literature review of studies on familial medullary thyroid cancer and MEN 2A kindreds.
• Analysis of genotype-phenotype correlations for non-cysteine RET mutations.
• Summary of existing data on RET codon 804 mutations.

Main Results:

• Non-cysteine RET mutations, including those at codon 804, are associated with a broad spectrum of phenotypes.
• Variable penetrance and diverse clinical courses are observed in patients with these mutations.
• The heterogeneity in disease expression has significant implications for diagnosis, treatment, and prognosis.

Conclusions:

• Non-cysteine RET mutations contribute to the clinical variability seen in MEN 2.
• Understanding these mutations is crucial for accurate patient management.
• Further research into RET codon 804 and other non-cysteine mutations is warranted.